Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline's Consumer Healthcare Unit Reportedly Attracting Private Equity Suitors; Shares Rise Pre-Bell

10/12/2021 | 08:30am EST


ę MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
01:21aSmith launches fresh attack on Unilever bosses
AQ
01/20Unilever Shareholder Calls for Improvement in Performance After Failed GSK-Pfizer Bid
MT
01/20ADRs Close Mostly Lower; Chinese Companies Traded Actively
DJ
01/20Global markets live: Unilever, United Airlines, Amazon, Walt Disney, Novavax...
01/20European ADRs Move Lower in Thursday Trading
MT
01/20Shareholder Terry Smith labels Unilever's GSK bid "near death experience"
RE
01/20MARKETSCREENER’S WORLD PRESS REVIEW : January 20, 2022
01/20EUROPEAN MIDDAY BRIEFING - Stocks Down After -2-
DJ
01/20NORTH AMERICAN MORNING BRIEFING : Stock Futures Inch Up After Nasdaq Enters Correction
DJ
01/20Unilever all but drops bid for GSK consumer arm
RE
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 892 M 46 071 M 46 071 M
Net income 2021 4 085 M 5 553 M 5 553 M
Net Debt 2021 20 812 M 28 291 M 28 291 M
P/E ratio 2021 20,3x
Yield 2021 4,89%
Capitalization 82 351 M 112 B 112 B
EV / Sales 2021 3,04x
EV / Sales 2022 2,84x
Nbr of Employees 94 066
Free-Float 92,2%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 1 636,60 GBX
Average target price 1 732,97 GBX
Spread / Average Target 5,89%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC1.87%112 398
JOHNSON & JOHNSON-2.62%438 538
ROCHE HOLDING AG-3.53%323 214
PFIZER, INC.-9.33%300 513
ABBVIE INC.-0.14%239 035
NOVO NORDISK A/S-12.67%223 059